How US FDA Will Unleash Attack On COVID-19 Variants Once Global Consensus Is Reached
Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.
Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.